---
$id: https://graph.org.ai/products/commodity/51323106
$type: Product
source: UNSPSC
code: "51323106"
title: "Fosmenic acid"
class: "51323100"
classTitle: "Antihyperlipidemics and hypocholesterolemics, synthesized"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fosmenic acid

**UNSPSC Code**: 51323106
**Class**: [Antihyperlipidemics and hypocholesterolemics, synthesized](Antihyperlipidemics and hypocholesterolemics, synthesized.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VD27I23138, chemically known as [cyclohex-3-en-1-yl(hydroxy)methyl]-hydroxy-oxo-phosphonium, which bears US NIH Compound Identifier 6338284, but generally known as fosmenic acid. European Medicines Agency schedules Fosmenic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07801MIG. Fosmenic acid generally arises in the molecular formula C7H13O3P. The term FOSMENIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) As of Q4 2014, FOSMENIC ACID remains the US FDA Preferred Term for this commodity. Fosmenic acid bears US NLM identifiers UMLS ID C1880847 and NCI Concept Code C65763. SMILES: P(=O)(O)C(O)C1CCC=CC1.

